icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back grey_arrow_rt.gif
 
 
 
RNA LAUNCH SYSTEM ENABLES IN VITRO EVALUATION OF BEPIROVIRSEN EFFICACY AGAINST HBV VARIANTS
 
 
  AASLD 2022 Nov 4-8
 
Yingpu Yu2*, Alexander Koenig1*, Christine Livingston1, Hardeep van Gijzel4, Rob Elston3, Dickens Theodore3, Melanie T. Paff3, Charles M. Rice2, Shihyun You1, William M. Schneider2*
1GSK, Upper Providence, PA, USA, Infectious Diseases Research Unit; 2The Rockefeller University, NY, USA, Laboratory of Virology and Infectious Disease; 3GSK, Upper Providence, PA, USA, Clinical Development; 4 GSK, Upper Providence, PA, USA, Human Genetics Computational Biology; *Contributes equally, Presenter

1110221

1110222

1110223

1110224

1110225